Value of Ki-67 in prediction of response to neoadjuvant chemotherapy in breast cancer

被引:0
|
作者
Kim, Kwanil [1 ]
Lee, Kyunghee [1 ]
Park, Heungkyu [1 ]
机构
[1] Gachon Univ Gil Hosp, Dept Surg, Inchon, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e12025
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [41] Treatment outcomes in triple negative breast cancer patients undergoing neoadjuvant chemotherapy. The importance of Ki-67
    Rapoport, Bernardo Leon
    Barnard-Tidy, Jacqui
    van Eeden, Ronwyn
    Smit, Teresa
    Nayler, Simon
    Benn, Carol
    CANCER RESEARCH, 2020, 80 (04)
  • [42] Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer
    Burcombe, Russell
    D Wilson, George
    Dowsett, Mitch
    Khan, Ifty
    Richman, Paul I.
    Daley, Frances
    Detre, Simone
    Makris, Andreas
    BREAST CANCER RESEARCH, 2006, 8 (03)
  • [43] Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer
    Russell Burcombe
    George D Wilson
    Mitch Dowsett
    Ifty Khan
    Paul I Richman
    Frances Daley
    Simone Detre
    Andreas Makris
    Breast Cancer Research, 8
  • [44] Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
    Chen, Rui
    Ye, Yin
    Yang, Chengcheng
    Peng, Yang
    Zong, Beige
    Qu, Fanli
    Tang, Zhenrong
    Wang, Yihua
    Su, Xinliang
    Li, Hongyuan
    Yang, Guanglun
    Liu, Shengchun
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (01) : 35 - 43
  • [45] Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
    Rui Chen
    Yin Ye
    Chengcheng Yang
    Yang Peng
    Beige Zong
    Fanli Qu
    Zhenrong Tang
    Yihua Wang
    Xinliang Su
    Hongyuan Li
    Guanglun Yang
    Shengchun Liu
    Breast Cancer Research and Treatment, 2018, 170 : 35 - 43
  • [46] Value of breast cancer molecular subtypes and Ki67 expression for the prediction of efficacy and prognosis of neoadjuvant chemotherapy in a Chinese population.
    Wang, Jiayu
    Xu, Binghe
    Sang, Die
    Zhang, Pin
    Li, Qing
    Yuan, Peng
    Ma, Fei
    Luo, Yang
    Fan, Ying
    Cai, Ruigang
    Chen, Shanshan
    Li, Qiao
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Role of Ki-67 in Carcinoma Breast as Predictive Marker of Pathological Response to Neoadjuvant Chemotherapy: A Cross-sectional Study
    Vinie, Mathew Mary
    Anjit, Unnikrishnan
    Jose, Lovely
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (07) : 42 - 45
  • [48] Triple Negative Breast Cancers with Low Ki-67 Proliferation Index: Clinical Pathologic Characteristics and Response to Neoadjuvant Chemotherapy
    Srivastava, Pooja
    Wang, Tiannan
    Carter, Gloria
    Clark, Beth
    Yu, Jing
    Fine, Jeffrey
    Villatoro, Tatiana
    Bhargava, Rohit
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 151 - 153
  • [49] Prediction of neoadjuvant chemotherapy response in breast cancer
    Izquierdo, M.
    Rodriguez, I.
    Tresserra, F.
    Baulies, S.
    Ara, C.
    Fabregas, R.
    BREAST, 2017, 32 : S79 - S79
  • [50] Prediction of neoadjuvant chemotherapy response in breast cancer
    Izquierdo, M.
    Rodriguez, I.
    Tresserra, F.
    Maria, G.
    Baulies, S.
    Ara, C.
    Fabregas, R.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S95 - S95